Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
Among several promising new drug-delivery systems, liposomes represent an advanced technology to deliver active molecules to the site of action, and at present several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles ("first-generation liposomes") to "second-generation liposomes", in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. A significant step in the development of long-circulating liposomes came with inclusion of the synthetic polymer poly-(ethylene glycol) (PEG) in liposome composition. The presence of PEG on the surface of the liposomal carrier has been shown to extend blood-circulation time while reducing mononuclear phagocyte system uptake (stealth liposomes). This technology has resulted in a large number of liposome formulations encapsulating active molecules, with high target efficiency and activity. Further, by synthetic modification of the terminal PEG molecule, stealth liposomes can be actively targeted with monoclonal antibodies or ligands. This review focuses on stealth technology and summarizes pre-clinical and clinical data relating to the principal liposome formulations; it also discusses emerging trends of this promising technology.
Immordino
Maria Laura
ML
Dipartimento di Scienza eTecnologia del Farmaco, University of Turin, Turin, Italy. marialaura.immordino@unito.it
Dosio
Franco
F
Cattel
Luigi
L
D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding / Q000379:methods*; D005544:Forecasting; D008081:Liposomes / Q000737:chemistry*; D008956:Models, Chemical; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry*
D004337:Drug Carriers; D008081:Liposomes; D004364:Pharmaceutical Preparations
Curr Opin Biotechnol. 2004 Dec;15(6):518-29
15560978
J Magn Reson Imaging. 2002 Oct;16(4):362-77
12353252
Curr Pharm Biotechnol. 2000 Sep;1(2):183-215
11467336
MAGMA. 2005 Sep;18(4):186-92
16155762
Gynecol Oncol. 2004 Apr;93(1):229-32
15047241
Biochim Biophys Acta. 1993 Mar 14;1146(2):157-68
8452853
Biosci Rep. 2002 Apr;22(2):225-50
12428902
Biochim Biophys Acta. 1992 Jan 31;1103(2):198-204
1543704
Pharm Res. 1997 Oct;14(10):1479-84
9358565
Clin Pharmacokinet. 2005;44(4):331-47
15828849
Int J Pharm. 2004 Feb 11;270(1-2):93-107
14726126
Nat Biotechnol. 2005 Sep;23(9):1147-57
16151408
Cancer. 2004 Mar 15;100(6):1199-207
15022287
Semin Oncol. 2004 Dec;31(6 Suppl 13):53-90
15717738
Biochim Biophys Acta. 1992 Jul 8;1108(1):40-8
1643080
Immunology. 1995 Sep;86(1):64-70
7590884
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949-53
3413128
J Pharmacol Exp Ther. 1999 Feb;288(2):665-70
9918573
Oncol Rep. 2005 Apr;13(4):589-95
15756428
Breast. 2004 Jun;13(3):219-26
15177425
Drugs R D. 2004;5(2):119-23
15293876
Drug Dev Ind Pharm. 2005 Jan;31(2):223-9
15773289
Biochim Biophys Acta. 1992 Feb 17;1104(1):95-101
1550858
Biomaterials. 2001 Nov;22(22):3035-44
11575478
Drug Deliv. 2004 Mar-Apr;11(2):123-8
15200011
Eur J Pharm Biopharm. 2005 Jan;59(1):177-87
15567316
Artif Cells Blood Substit Immobil Biotechnol. 2005;33(2):137-62
15960077
J Pharmacol Exp Ther. 2001 Aug;298(2):607-12
11454922
Adv Drug Deliv Rev. 2005 Apr 5;57(5):699-712
15757756
Pharm Res. 2001 Jul;18(7):1042-8
11496943
Anticancer Drugs. 2004 Jun;15(5):499-502
15166625
J Biol Chem. 1992 Sep 15;267(26):18759-65
1527006
Biochim Biophys Acta. 1993 Jul 25;1150(1):9-16
8334142
J Clin Oncol. 2004 Oct 1;22(19):3916-21
15459213
Br J Cancer. 2000 Sep;83(5):684-8
10944612
J Pharm Sci. 2005 May;94(5):1024-38
15793796
Ann Oncol. 2005 Feb;16(2):300-6
15668288
J Clin Oncol. 2005 Mar 20;23(9):1859-66
15699482
J Control Release. 2004 Aug 11;98(2):195-207
15262412
Biochim Biophys Acta. 1981 Sep 24;665(3):538-45
7295749
Pharm Res. 1994 Mar;11(3):402-6
8008707
Biosci Rep. 2002 Apr;22(2):197-224
12428901
J Control Release. 2000 Jan 3;63(1-2):19-30
10640577
Arch Biochem Biophys. 1998 Sep 15;357(2):185-94
9735159
Pharmacol Rev. 1999 Dec;51(4):691-743
10581328
Biochim Biophys Acta. 1996 May 22;1281(1):31-7
8652601
J Control Release. 2001 Jul 6;74(1-3):47-61
11489482
Bioconjug Chem. 1998 Jul-Aug;9(4):418-50
9667945
Br J Cancer. 2000 Jul;83(2):232-8
10901376
Biochim Biophys Acta. 1994 Apr 20;1191(1):43-51
8155683
J Leukoc Biol. 1986 Jan;39(1):1-12
3455706
Ann Oncol. 2004 Mar;15(3):517-25
14998859
Drugs Today (Barc). 2004 Feb;40(2):133-45
15045035
Bioconjug Chem. 1994 Nov-Dec;5(6):493-6
7873652
Semin Oncol. 2004 Dec;31(6 Suppl 13):36-52
15717737
Cancer Res. 2003 Jun 15;63(12):3154-61
12810643
Bioconjug Chem. 1999 Sep-Oct;10(5):703-7
10502334
Prog Lipid Res. 2002 Sep;41(5):392-406
12121719
Cancer Res. 2004 Nov 1;64(21):8002-8
15520208
J Pharm Sci. 1995 Sep;84(9):1049-53
8537880
J Control Release. 2001 Jul 10;75(1-2):83-91
11451499
J Control Release. 2003 Sep 4;91(3):417-29
12932719
J Immunol. 1981 May;126(5):1820-5
7217669
Cancer. 2000 Sep 1;89(5):1037-47
10964334
J Biol Chem. 1995 Oct 27;270(43):25845-9
7592769
Blood. 2004 Sep 1;104(5):1442-9
15155467
Cancer Res. 2000 Jul 1;60(13):3389-93
10910044
Int J Pharm. 2000 Sep 15;205(1-2):101-8
11000546
J Cancer Res Clin Oncol. 2003 Oct;129(10):549-55
14513369
J Biol Chem. 2005 Apr 22;280(16):15619-27
15695518
Vaccine. 1999 Mar 5;17(9-10):1223-38
10195636
Crit Rev Ther Drug Carrier Syst. 1987;3(2):123-93
3542245
Anticancer Res. 2005 Jul-Aug;25(4):3031-9
16080562
J Control Release. 2004 Nov 5;100(1):135-44
15491817
J Immunol. 1991 Jun 15;146(12):4234-41
2040798
Biochim Biophys Acta. 1991 Jul 1;1066(1):29-36
2065067
Cancer Chemother Pharmacol. 2004 May;53(5):452-7
14749894
Cancer Sci. 2004 Jul;95(7):608-13
15245599
Biochim Biophys Acta. 1992 Jul 27;1108(2):257-60
1637850
Clin Cancer Res. 2002 Apr;8(4):1172-81
11948130
Biochim Biophys Acta. 1994 Oct 12;1195(1):181-4
7918561
Adv Drug Deliv Rev. 2005 Feb 28;57(4):637-51
15722168
Semin Oncol. 2004 Dec;31(6 Suppl 13):147-60
15717741
Crit Rev Ther Drug Carrier Syst. 1992;9(1):39-90
1544174
J Pharm Sci. 1994 Apr;83(4):601-6
8046623
Ann N Y Acad Sci. 1985;446:368-84
2409883
Biochim Biophys Acta. 2001 Jun 6;1512(2):191-205
11406096
J Control Release. 2005 Jul 20;105(3):305-17
15908032
Nat Biotechnol. 1999 Aug;17(8):775-9
10429242
J Liposome Res. 2001;11(2-3):153-64
19530930
Biotechnol Prog. 2005 Jan-Feb;21(1):221-32
15903261
J Pharm Pharm Sci. 2003 May-Aug;6(2):292-301
12935441
J Cereb Blood Flow Metab. 2003 Aug;23(8):895-9
12902833
Methods Enzymol. 2004;387:33-50
15172156
Biochim Biophys Acta. 1994 Oct 12;1195(1):11-20
7918551
Immunol Cell Biol. 2005 Apr;83(2):97-105
15748206
Biochim Biophys Acta. 2003 Apr 1;1611(1-2):204-16
12659962
Curr Opin Investig Drugs. 2001 Apr;2(4):488-95
11566004
J Biol Chem. 1998 Jun 19;273(25):15621-7
9624154
Cancer Res. 1993 Oct 15;53(20):4913-9
8402681
Curr Opin Biotechnol. 2005 Feb;16(1):89-92
15722020
Int J Cancer. 2004 Jan 10;108(2):301-6
14639619
Oncologist. 2005 Mar;10(3):205-14
15793224
J Control Release. 2003 Aug 28;91(1-2):123-33
12932644
Cancer Res. 2003 Jan 1;63(1):86-92
12517782
FEBS Lett. 1982 Aug 16;145(1):109-14
6897042
Adv Drug Deliv Rev. 2005 Jun 17;57(9):1247-65
15935873
Semin Oncol. 2004 Dec;31(6 Suppl 13):106-46
15717740
Int J Cancer. 2004 Nov 20;112(4):693-700
15382053
Curr Pharm Des. 2004;10(24):2981-9
15379663
Anticancer Res. 2003 Jul-Aug;23(4):3341-5
12926073
Ann Oncol. 2001 Apr;12(4):493-6
11398881
Biochim Biophys Acta. 1993 Nov 7;1179(2):157-65
8218358
Biochim Biophys Acta. 2002 Jan 2;1558(1):1-13
11750259
Cancer Biol Ther. 2006 Jan;5(1):89-96
16357513
Adv Genet. 2005;54:315-37
16096017
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2959-63
208079
Semin Oncol. 2004 Dec;31(6 Suppl 13):5-15
15717735
Int J Cancer. 1999 Mar 1;80(5):723-30
10048974
Prog Lipid Res. 2003 Nov;42(6):463-78
14559067
Cancer Res. 2000 Dec 15;60(24):6942-9
11156394
J Liposome Res. 2004;14(3-4):155-73
15676124
J Biol Chem. 1990 Mar 25;265(9):5226-31
2318890
Biochim Biophys Acta. 1989 May 19;981(1):27-35
2719971
Biochim Biophys Acta. 1999 Jul 15;1419(2):325-34
10407083
Crit Rev Ther Drug Carrier Syst. 1990;6(4):315-65
2186872
Biotechnol Prog. 2005 Jan-Feb;21(1):205-20
15903260
Drugs R D. 1999 Feb;1(2):181-3
10566021
Prog Lipid Res. 2003 Sep;42(5):439-62
12814645
Pharmacol Ther. 1993 Nov;60(2):215-34
8022858
J Biomater Sci Polym Ed. 2000;11(12):1307-17
11261873
J Control Release. 2004 Jul 23;98(1):87-95
15245892
Methods Enzymol. 2005;391:163-76
15721380
Lung Cancer. 2001 Dec;34(3):427-32
11714540
Adv Drug Deliv Rev. 2003 Sep 26;55(10):1261-77
14499706
Pharm Res. 2002 Oct;19(10):1430-8
12425459
Br J Cancer. 2001 Jan;84(2):157-63
11161370
Biochim Biophys Acta. 2001 Jul 2;1513(1):25-37
11427191
Bioconjug Chem. 2003 Nov-Dec;14(6):1156-64
14624629
Cancer Chemother Pharmacol. 2004 Apr;53(4):329-36
14673619
Adv Drug Deliv Rev. 2000 Mar 30;41(2):135-46
10699310
J Clin Oncol. 2005 May 20;23(15):3495-501
15908659
Methods Enzymol. 2005;391:145-62
15721379
Curr Mol Med. 2004 Sep;4(6):681-9
15357216
Biochim Biophys Acta. 1994 Jun 1;1192(1):35-44
8204648